Low‐dose diazoxide is safe and effective in infants with transient hyperinsulinism
Clinical Endocrinology · 2024
DOI: 10.1111/cen.14987 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Endocrinology, 2024. Verfasst von Neha Malhotra und 8 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology Department, Great Ormond Street Hospital for Children, London, UK. Hauptthemen laut MEDLINE: Hypoglycemia, Hyperinsulinism, Congenital Hyperinsulinism. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
Objective Transient hyperinsulinism (THI) is the most common form of recurrent hypoglycaemia in neonates beyond the first week of life. Although self‐resolving, treatment can be required. Consensus guidelines recommend the lower end of the diazoxide 5–15 mg/kg/day range in THI to reduce the risk of adverse events. We sought to determine if doses
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Endocrinology Department, Great Ormond Street Hospital for Children, London, UK.
- Department of Pediatrics, Division of Endocrinology, University of Saskatchewan, Saskatoon, Canada.
- Faculty of Medicine and Dentistry, Medical School of Queen Mary University, London, UK.
Zitieren
APA
Malhotra, N., Yau, D., Cunjamalay, A., Gunasekara, B., S, A., Gilbert, C., Morgan, K., Dattani, M., & Dastamani, A. (2024). Low‐dose diazoxide is safe and effective in infants with transient hyperinsulinism. Clinical Endocrinology. https://doi.org/10.1111/cen.14987
Vancouver
Malhotra N, Yau D, Cunjamalay A, Gunasekara B, S A, Gilbert C, et al. Low‐dose diazoxide is safe and effective in infants with transient hyperinsulinism. Clinical Endocrinology. 2024. doi:10.1111/cen.14987
BibTeX
@article{Malhotra2024,
author = {Malhotra, Neha and Yau, Daphne and Cunjamalay, Annaruby and Gunasekara, Buddhi and S, Athanasakopoulou and Gilbert, Clare and Morgan, Kate and Dattani, Mehul and Dastamani, Antonia},
title = {Low‐dose diazoxide is safe and effective in infants with transient hyperinsulinism},
journal = {Clinical Endocrinology},
year = {2024},
doi = {10.1111/cen.14987}
}
EUVIMED